Pharmacogenetic (PGx) testing refers to testing for specific genetic variants that could have an impact on drug response. The U.S. Food and Drug Administration has recognized this testing as playing an important role in avoiding potentially dangerous side effects and optimizing drug dosing. Pharmacogenomics is now being implemented into routine clinical practice as the medical and pharmaceutical industries move from a one-size-fits-all model to a
precision medicine approach.
A simple cheek swab can help clinicians understand which medications may work best for individual patients based on their unique genetics. This once-in-a-lifetime test can help eliminate the expensive, time consuming, and painful trial-and-error process to prescribing medication and can quickly achieve better patient outcomes.
Most commonly, pharmacogenetic testing candidates fall into
the following categories:
Patients with a history of angina
Mental health patients: history of major depressive disorder
Pain patients: history of major depressive disorder
Copyright © 2020 Xact Laboratories - All Rights Reserved.